pain-management-internal-medicine-2019-posters-abstracts

28 / 46

Pain Management 2019 & Internal Medicine 2019 International Journal of Anesthesiology & Pain Medicine
ISSN: 2471-982X Page 66
JOINT EVENT
7th Edition of International Conference on
Pain Management
8th Edition of International Conference on
Internal Medicine &
Patient Care
&
March 25-26, 2019
Rome, Italy
Int J Anesth Pain Med 2019, Volume 5
DOI: 10.21767/2471-982X-C1-006
Omega-3 fatty acids: A novel approach for pain treatment
Carlos H Laino
National University of La Rioja, Argentina
The treatment of acuteandchronicseverepain remains
a common major challenge faced by clinicians
working with the general population, and even after
recent advances in the treatment of acute and chronic
severe pain, there can continue to be manifestations of
adverse effects. Chronic pain affects the personal and
social life of the patient, and often also their families. In
some cases, after an acute pain the patient continues to
experience chronic pain, which can be a result of diseases
such as cancer. There is growing evidence that omega-3
fatty acids can contribute to the reduction of pain. This
presentation will describe an innovative technological
development, both in its pharmaceutical composition
(either morphine or methadone with omega-3 fatty
acids) and in the pharmacological treatments associated
with its use. In addition, the preclinical evidence
concerning the analgesic effects of omega-3 fatty
acids (eicosapentaenoic acid and docosahexaenoic
acid) will also be explored. The main advantage of new
pharmacological treatments using these pharmaceutical
compositions lies in an improved pain control with a
sub-therapeutic dose of these opioids, which can lead to
the elimination or at least potential reduction of adverse
effects.